| PERIOD ENDING | 25-Sep-09 | 26-Jun-09 | 27-Mar-09 | 26-Dec-08 | | Total Revenue | 2,289,000 | 2,185,000 | 2,247,000 | 2,674,000 | | Cost of Revenue | 2,796,000 | 324,000 | 1,024,000 | 2,083,000 | | | Gross Profit | (507,000) | 1,861,000 | 1,223,000 | 591,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | (1,333,000) | 1,050,000 | 477,000 | (329,000) | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 228,000 | 229,000 | 224,000 | 228,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 598,000 | 582,000 | 522,000 | 692,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 6,000 | 22,000 | (9,000) | (172,000) | | Earnings Before Interest And Taxes | 604,000 | 604,000 | 513,000 | 520,000 | | Interest Expense | 140,000 | 139,000 | 141,000 | 136,000 | | Income Before Tax | 464,000 | 465,000 | 372,000 | 384,000 | | Income Tax Expense | 171,000 | 172,000 | 126,000 | 137,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 293,000 | 293,000 | 246,000 | 247,000 | | | Non-recurring Events | | Discontinued Operations |
-
| 15,000 |
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 293,000 | 308,000 | 246,000 | 247,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $293,000 | $308,000 | $246,000 | $247,000 |
|
2.03% Nasdaq 
Income Statement
